Re-Engineering Diagnostics Through Photonics

MediivaHealth is building a scalable, multi-spectral photonic platform designed to enable next-generation non-invasive biochemical and hemodynamic assessment architectures.

Platform

Drishti-Bio is a laboratory-stage photonic sensing platform integrating multi-spectral optical emission, signal modeling and hemodynamic gating architecture.

The core objective is to establish a scalable non-invasive biochemical signal acquisition framework capable of replacing invasive sampling pathways in the long term.

Prototype validation and signal modeling are currently in controlled laboratory phase.

Why Now

Biochemical Access Bottleneck

Over-reliance on invasive diagnostics limits accessibility in decentralized healthcare systems.

Advances in Photonics + AI

Recent progress in optical miniaturization and computational modeling enables new diagnostic architectures.

Technology & Clinical Development Pathway

Prototype & Signal Validation

Alpha architecture development and foundational signal modeling under controlled laboratory conditions.

Regulatory & Quality Structuring

Test licensing, ethics approvals, ISO 13485 implementation and structured compliance alignment.

Clinical Correlation & Safety Certification

Controlled pilot and pivotal studies, IEC 60601 validation and regulatory submission.

Commercial Readiness & Early Deployment

Device calibration, manufacturing refinement and scalable market entry strategy.

Contact

Registered Office

MEDIIVAHEALTH PRIVATE LIMITED
PoleStar CoWorking Space, 3rd Floor,
Vijayanagar, Bangalore - 560040,
Karnataka, India

Inquiries

Email: info@mediivahealth.in

WhatsApp: +91 7019517775

Today's Visitors: 0 | Total Visitors: 0